146 related articles for article (PubMed ID: 36842094)
21. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.
Agnholt J; Kelsen J; Schack L; Hvas CL; Dahlerup JF; Sørensen ES
Scand J Immunol; 2007 May; 65(5):453-60. PubMed ID: 17444956
[TBL] [Abstract][Full Text] [Related]
22. Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
Morgan NN; Duck LW; Wu J; Rujani M; Thomes PG; Elson CO; Mannon PJ
Inflamm Bowel Dis; 2022 Dec; 28(12):1893-1903. PubMed ID: 35931421
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling.
Liu C; Dunkin D; Lai J; Song Y; Ceballos C; Benkov K; Li XM
Inflamm Bowel Dis; 2015 Aug; 21(8):1918-25. PubMed ID: 25993687
[TBL] [Abstract][Full Text] [Related]
24. Intestinal CD14+ Macrophages Protect CD4+ T Cells From Activation-induced Cell Death via Exosomal Membrane TNF in Crohn's Disease.
Liu H; Liang Z; Wang F; Zheng X; Zeng Z; He X; Gao X; Zhi M; Wu X; Wu X; Lan P
J Crohns Colitis; 2020 Nov; 14(11):1619-1631. PubMed ID: 32343772
[TBL] [Abstract][Full Text] [Related]
25. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity.
Tamandl D; Bahrami M; Wessner B; Weigel G; Ploder M; Fürst W; Roth E; Boltz-Nitulescu G; Spittler A
Shock; 2003 Sep; 20(3):224-9. PubMed ID: 12923493
[TBL] [Abstract][Full Text] [Related]
26. Crohn's Disease Patients with Depression Exhibit Alterations in Monocyte/Macrophage Phenotype and Increased Proinflammatory Cytokine Production.
Tang Y; Zhao L; Lei N; Chen P; Zhang Y
Dig Dis; 2020; 38(3):211-221. PubMed ID: 31216541
[TBL] [Abstract][Full Text] [Related]
27. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
[TBL] [Abstract][Full Text] [Related]
28. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.
Segain JP; Raingeard de la Blétière D; Bourreille A; Leray V; Gervois N; Rosales C; Ferrier L; Bonnet C; Blottière HM; Galmiche JP
Gut; 2000 Sep; 47(3):397-403. PubMed ID: 10940278
[TBL] [Abstract][Full Text] [Related]
29. Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashion.
Gu J; Liu G; Xing J; Song H; Wang Z
Microb Pathog; 2018 Aug; 121():40-44. PubMed ID: 29752990
[TBL] [Abstract][Full Text] [Related]
30. CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy.
Maggi L; Capone M; Giudici F; Santarlasci V; Querci V; Liotta F; Ficari F; Maggi E; Tonelli F; Annunziato F; Cosmi L
Int Arch Allergy Immunol; 2013; 161(1):81-6. PubMed ID: 23257766
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.
Griga T; Werner S; Köller M; Tromm A; May B
Dig Dis Sci; 1999 Jun; 44(6):1196-201. PubMed ID: 10389696
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
[TBL] [Abstract][Full Text] [Related]
33. SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction.
Fernandes S; Srivastava N; Sudan R; Middleton FA; Shergill AK; Ryan JC; Kerr WG
Front Immunol; 2018; 9():1100. PubMed ID: 29872435
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease.
Xia H; Li S; He Y; Ren Q; Qin S
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101895. PubMed ID: 35227955
[TBL] [Abstract][Full Text] [Related]
35.
Schäffler H; Rohde M; Rohde S; Huth A; Gittel N; Hollborn H; Koczan D; Glass Ä; Lamprecht G; Jaster R
World J Gastroenterol; 2018 Mar; 24(11):1196-1205. PubMed ID: 29568200
[TBL] [Abstract][Full Text] [Related]
36. NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation.
Hedl M; Abraham C
Am J Physiol Gastrointest Liver Physiol; 2013 Mar; 304(6):G583-96. PubMed ID: 23287275
[TBL] [Abstract][Full Text] [Related]
37. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls.
Bouma G; Oudkerk Pool M; Scharenberg JG; Kolkman JJ; von Blomberg BM; Scheper RJ; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Nov; 30(11):1095-100. PubMed ID: 8578170
[TBL] [Abstract][Full Text] [Related]
38. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
[TBL] [Abstract][Full Text] [Related]
39. Cytokine network in rectal mucosa in perianal Crohn's disease: relations with inflammatory parameters and need for surgery.
Ruffolo C; Scarpa M; Faggian D; Pozza A; Navaglia F; D'Incà R; Hoxha P; Romanato G; Polese L; Sturniolo GC; Plebani M; D'Amico DF; Angriman I
Inflamm Bowel Dis; 2008 Oct; 14(10):1406-12. PubMed ID: 18452203
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
